MORPHINE REDUCES THE RELEASE OF MET-ENKEPHALIN-LIKE MATERIAL FROM THE RAT SPINAL-CORD IN-VIVO BY ACTING AT DELTA-OPIOID RECEPTORS

The modulation by morphine of the spinal release of met-enkephalin-like material (MELM) was investigated in anaesthetized rats whose intrathecal space was perfused with an artificial CSF (ACSF). Morphine (10 mu M in the ACSF), as well as a mu- (DAGO, 10 mu M) or delta opioid receptor agonist (DTLET, 10 mu M), significantly decreased the outflow of MELM. The effects of morphine and DTLET were prevented by the delta antagonist, naltrindole (10 mu M), but not by naloxone (10 mu M) Conversely, naloxone, but not naltrindole, prevented the inhibitory effect of DAGO. Although neither the ii, agonist, U 50488H (10 mu M), nor the kappa(1), antagonist, norbinaltorphimine (10 mu M), exerted on their own any significant effect, norbinaltorphimine enhanced the inhibitory action of morphine. In contrast to the inhibition induced by morphine (with or without naloxone) which was preventable by 10 mu M naltrindole, the inhibition of MELM release by morphine plus norbinaltorphimine was only partly reduced by naltrindole. Thus, concomitant stimulation of mu, delta and kappa(1) receptors might account for the apparent delta opioid receptor-dependent inhibition of MELM release by morphine. Indeed, its potential inhibitory effect through the stimulation of mu receptors (normally prevented by the concomitant stimulation of kappa(1) receptors) becomes efficient only when kappa(1) receptors are blocked.